Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C Virus (HCV)

Explore clinical trials studying Hepatitis C Virus (HCV). Study availability and eligibility vary by location and protocol.

27 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C Virus (HCV) trial results

Recruiting

California MEPS Hub

NCT07433985

Conditions
Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +23 more
Locations
  • CAL-PEP Oakland, California, United States
  • Kindful Restoration Riverside, California, United States
  • Starting Over, Inc Riverside, California, United States
View Trial Details
Recruiting

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

NCT07122219

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • Edmonton Institution for Women Edmonton, Alberta, Canada
  • Fraser Valley Institution for Women Abbotsford British Columbia, British Columbia, Canada
  • Mission Institution Mission, British Columbia, Canada
  • Dorchester Medium Dorchester, New Brunswick, Canada
View Trial Details
Not Yet Recruiting

Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System

NCT07406490

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +26 more
Locations
  • UF Health Shands Emergency Room / Trauma Center Gainesville, Florida, United States
  • UF Health Jacksonville Emergency Room Jacksonville, Florida, United States
  • UF Health North Emergency Room Jacksonville, Florida, United States
View Trial Details
Completed

A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

NCT04214028

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Kariya Toyota General Hospital /ID# 239046 Kariya-shi, Aichi-ken, Japan
  • Meijo Hospital /ID# 250955 Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital /ID# 226746 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 238745 Nagoya, Aichi-ken, Japan
View all 54 locations
View Trial Details
Completed

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

NCT04903626

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Arizona Health Research /ID# 233558 Chandler, Arizona, United States
  • The Institute for Liver Health /ID# 228427 Peoria, Arizona, United States
  • Liver Wellness Center /ID# 244933 Little Rock, Arkansas, United States
  • AHF Research Center /ID# 254795 Beverly Hills, California, United States
View all 70 locations
View Trial Details
Completed

A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers

NCT04366973

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Centre de soin d'accompagnement et de prevention en addictologie- CHU Archet 2 /ID# 218682 Nice, Alpes-Maritimes, France
  • Centre de Soins d'Accompagnement et de Prevention en Addictologie-Tempo Oppelia /ID# 218701 Valence, Drome, France
  • CSAPA Bagnols sur ceze /ID# 233397 Bagnols-sur-Cèze, Gard, France
  • Centre de soin d'accompagnement et de prevention en addictologie- L'ENVOL /ID# 218680 Nîmes, Gard, France
View all 30 locations
View Trial Details
Completed

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

NCT04577482

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • South Ural State Medical University /ID# 226555 Chelyabinsk, Russia
  • LLC Center of Targeted Therapy /ID# 239529 Domodedovo, Russia
  • Irkutsk Regional Center for the Prevention and Control of AIDS and Infections /ID# 229509 Irkutsk, Russia
  • Specialized Clinical Infectious Diseases Hospital /ID# 229814 Krasnodar, Russia
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

NCT03067129

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations
  • Univ of California San Francis /ID# 158002 San Francisco, California, United States
  • Childrens Hospital Colorado /ID# 157996 Aurora, Colorado, United States
  • CT Childrens Medical Ctr, US /ID# 158639 Hartford, Connecticut, United States
  • UF Hepatology Research at CTRB /ID# 158008 Gainesville, Florida, United States
View all 38 locations
View Trial Details

Related conditions